Revvity Inc. Declares Quarterly Dividend of $0.07 (NYSE:RVTY)

Key Points

• Revvity Inc. announced a quarterly dividend of $0.07 per share, with an ex-dividend date of January 16th, and payment scheduled for February 6th, resulting in an annual yield of 0.3%.
• The company reported earnings of $1.18 per share for its last quarter, exceeding expectations, and has set forecasted earnings for FY 2025 between 4.850-4.950 EPS.
• Revvity's stock opened at $97.69, with a market capitalization of $11.34 billion, and has seen a revenue increase of 4.1% year-over-year.

Revvity Inc. (NYSE:RVTY - Get Free Report) announced a quarterly dividend on Thursday, October 23rd. Shareholders of record on Friday, January 16th will be given a dividend of 0.07 per share on Friday, February 6th. This represents a c) dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Friday, January 16th.

Revvity has a dividend payout ratio of 5.1% indicating that its dividend is sufficiently covered by earnings. Analysts expect Revvity to earn $5.56 per share next year, which means the company should continue to be able to cover its $0.28 annual dividend with an expected future payout ratio of 5.0%.

Revvity Stock Up 2.1%

RVTY opened at $97.69 on Friday. Revvity has a fifty-two week low of $81.36 and a fifty-two week high of $129.50. The company has a debt-to-equity ratio of 0.43, a current ratio of 3.33 and a quick ratio of 2.75. The firm's fifty day moving average price is $89.22 and its two-hundred day moving average price is $92.37. The company has a market capitalization of $11.34 billion, a P/E ratio of 41.39, a P/E/G ratio of 3.19 and a beta of 0.98.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings data on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.14 by $0.04. The company had revenue of $720.28 million during the quarter, compared to analysts' expectations of $711.26 million. Revvity had a return on equity of 7.66% and a net margin of 10.19%.The business's revenue was up 4.1% on a year-over-year basis. During the same period last year, the business earned $1.22 earnings per share. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. On average, analysts anticipate that Revvity will post 4.94 EPS for the current year.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.